Chemotherapy Devices MarketSize and Trends
Global chemotherapy devices market is estimated to be valued at US$ 17 Bn in 2023, and is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).
Figure 1. Global Chemotherapy Devices Market Share (%), By Product, 2023
Figure 2. Global Chemotherapy Devices Market Share (%), By Region, 2023
Global Chemotherapy Devices Market Report Coverage
Global Chemotherapy Devices Market : Trends
- Increasing organic growth strategies such as product approval: Increasing organic growth strategies such as product approval by regulatory authorities to expand key market players’ product portfolio is expected to drive the market growth over the forecast period. For instance, in September 2021, RenovoRx, Inc., a biopharmaceutical company, announced that it had received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary RenovoCath Delivery System. The RenovoCath Delivery System is the device component of the company\'s initial product named RenovoGem. This drug/device combination used in RenovoRx's Trans-Arterial Micro-Perfusion (RenovoTAMP) therapy platform is a dual-balloon infusion catheter delivering chemotherapy directly to tumors via arteries.